AbbVie to Acquire Apogee Therapeutics for $10.9B
SAN DIEGO — AbbVie has agreed to acquire Apogee Therapeutics for $10.9 billion, the companies said today, in a deal designed to bolster the buyer’s pipeline with an atopic dermatitis (AD) candidate set to advance to Phase III trials during the second half of this year, and being positioned as a potential challenger to a top-selling drug.
专利壁垒、登记雷区与合规生存法则,以氟唑菌酰胺/砜吡草唑等热点产品为例解析农药出海″隐形雷区″
中国是全球最大的农药生产国和出口国,超过九成的农药产量依赖出口市场。然而,随着国际农化巨头专利维权力度的持续升级,以及各国监管法规的日趋严苛,中国农药企业出海的道路正变得越来越崎岖。2025年-2026年,巴斯夫就氟唑菌酰胺专利侵权发出维权申明;与此同时,日本组合化学围绕砜吡草唑关键中间体专利的全球维权行动持续升级。农药出海已从″市场争夺战″演变为″法律合规战″。
Brain-Infiltrating T Cells Linked to Social Deficits in Autism Mouse Model
The prevalence of autism spectrum disorder (ASD) is roughly one in 36 people, with a male-to-female ratio of 4:1. The disorder is known to be influenced by multiple factors, both genetic (gene mutations and copy number variations) and environmental, such as infections during pregnancy. However, the role of immunity in genetic ASD remains unclear.
利尔化学控股权转让征集期满,10家意向受让企业参与竞逐
世界农化网中文网报道:2026年6月22日,利尔化学股份有限公司(简称″利尔化学″,证券代码:002258)发布公告称,其控股股东久远集团及一致行动人化材科技合计转让23.50%股份的公开征集期已于6月17日届满,共有10家意向受让方提交申请材料并足额缴纳保证金。意味着利尔化学控股权变更事宜进入实质性评审阶段,引发行业高度关注。
Breast Milk Fatty Acid Shapes Immune Development in Mice
In a new study published in Science titled, “ Maternal trans-vaccenic acid shapes neonatal T cell development and early-life immune imprinting , ” researchers from the University of Chicago have found that trans-vaccenic acid (TVA), the most abundant trans fatty acid in human breast milk, helps boost immune system development in mice.
历时七年,欧盟新基因组技术(NGTs)法规尘埃落定!种业巨头集体″点赞″
世界农化网中文网报道:2026年6月17日,欧洲议会正式通过了关于植物"新基因组技术"(NGTs)的最终法规草案。继欧盟理事会于2026年4月21日通过一读立场、并于5月正式将法案移交议会后,欧盟立法程序至此全部完成。欧洲由此正式告别了自2001年《指令2001/18/EC》实施以来沿用逾25年的转基因(GMO)过程导向型监管体制。
江山股份再融资获证监会批准,11.85亿元投向苯嘧草唑与精异丙甲草胺产能提升
世界农化网中文网报道:6月18日,南通江山农药化工股份有限公司(简称″江山股份″)发布公告称,收到中国证监会出具的《关于同意南通江山农药化工股份有限公司向不特定对象发行可转换公司债券注册的批复》,同意公司向不特定对象发行可转换公司债券的注册申请。
巴斯夫新型杀菌剂flufenoxadiazam获FRAC新作用机制认定,列入Group 56
世界农化网中文网报道:巴斯夫农业解决方案部门旗下新型杀菌剂活性成分Adapzo® Active(通用名:flufenoxadiazam)日前获得杀菌剂抗性行动委员会(FRAC)的全新作用机制认定,被正式列入新设立的″FRAC Group 56″。该成分为全球首个组蛋白去乙酰化酶(HDAC)抑制剂,也是该组别中唯一的代表成分。结构上,该分子属于苯甲酰苯胺或者噁二唑类。
明德立达纳米杀菌剂——纳米明安®在厄瓜多尔上市,高效防控马铃薯晚疫病
马铃薯晚疫病是马铃薯生产中危害最严重的病害之一,对马铃薯产量和品质构成了重大威胁。近日,纳米杀菌剂纳米明安®在厄瓜多尔全新上市,为当地马铃薯种植者更高效地防控晚疫病提供了新的解决方案。
Could Light Be the Solution to Unlocking Cell-Based Coffee?
Israeli food tech startups Coffeesai and Brevel have teamed up to accelerate the production of cell-based coffee with light as a key ingredient.
